相似文献
1
Discovery and development of new antibiotics: the problem of antibiotic resistance.新型抗生素的发现与研发：抗生素耐药性问题
Antimicrob Agents Chemother. 1993 Mar;37(3):377-83. doi: 10.1128/AAC.37.3.377.
2
Using computers to ESKAPE the antibiotic resistance crisis.利用计算机应对ESKAPE耐药危机。
Drug Discov Today. 2022 Feb;27(2):456-470. doi: 10.1016/j.drudis.2021.10.005. Epub 2021 Oct 21.
3
Antibiotic resistance: what, why, where, when and how?抗生素耐药性：是什么、为什么、在哪里、何时以及如何？
Br Med Bull. 2015;116:105-13. doi: 10.1093/bmb/ldv041. Epub 2015 Oct 21.
4
Nano-technology for targeted drug delivery to combat antibiotic resistance.纳米技术用于靶向药物输送以对抗抗生素耐药性。
Expert Opin Drug Deliv. 2012 Nov;9(11):1325-32. doi: 10.1517/17425247.2012.717927. Epub 2012 Aug 28.
5
The impact of bacterial genomics on antibacterial discovery.
Adv Exp Med Biol. 1998;456:183-95. doi: 10.1007/978-1-4615-4897-3_10.
6
[Prevention of resistance to antibiotics. A complex problem].
Presse Med. 1998 Jun;27 Suppl 3:3.
7
Biofilms: Microbial Shelters Against Antibiotics.生物膜：抵御抗生素的微生物庇护所
Microb Drug Resist. 2017 Mar;23(2):147-156. doi: 10.1089/mdr.2016.0087. Epub 2016 May 23.
8
Exploiting current understanding of antibiotic action for discovery of new drugs.利用当前对抗生素作用的认识来发现新药。
Symp Ser Soc Appl Microbiol. 2002(31):4S-15S.
9
[Antibiotics: new mechanisms of resistance transfer].
Antibiot Khimioter. 1998;43(6):3-6.
10
Children as agents of change in combatting antibiotic resistance.儿童作为对抗抗生素耐药性的变革推动者。
J Health Serv Res Policy. 2017 Oct;22(4):258-260. doi: 10.1177/1355819617701512. Epub 2017 Mar 27.
引用本文的文献
1
Targeting the G-quadruplex as a novel strategy for developing antibiotics against hypervirulent drug-resistant Staphylococcus aureus.靶向G-四链体作为开发抗高毒力耐药金黄色葡萄球菌抗生素的新策略。
J Biomed Sci. 2025 Feb 5;32(1):15. doi: 10.1186/s12929-024-01109-3.
2
The fall of the mycobacterial cell wall: interrogating peptidoglycan synthesis for novel anti-TB agents.分枝杆菌细胞壁的瓦解：针对新型抗结核药物对肽聚糖合成的探索。
PeerJ. 2024 Nov 14;12:e18404. doi: 10.7717/peerj.18404. eCollection 2024.
3
High-Throughput Mining of Novel Compounds from Known Microbes: A Boost to Natural Product Screening.高通量挖掘已知微生物中的新型化合物：天然产物筛选的助推器。
Molecules. 2024 Jul 8;29(13):3237. doi: 10.3390/molecules29133237.
4
Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery.将细菌分子遗传学与化学生物学相结合，重新发现抗菌药物。
Biochem J. 2024 Jul 3;481(13):839-864. doi: 10.1042/BCJ20220062.
5
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.皮肤鳞状细胞癌的分子靶向治疗：最新进展与临床意义
EXCLI J. 2024 Feb 27;23:300-334. doi: 10.17179/excli2023-6489. eCollection 2024.
6
Planning and development of an antimicrobial stewardship program in penitentiary facilities: strategies to optimize therapeutic prescribing and reduce the incidence of antibiotic resistance.监狱设施中抗菌药物管理计划的规划和制定：优化治疗性处方和降低抗生素耐药发生率的策略。
Front Public Health. 2023 Oct 25;11:1233522. doi: 10.3389/fpubh.2023.1233522. eCollection 2023.
7
Total Synthesis and Biological Investigation of Mindapyrroles A and B.咪达吡咯 A 和 B 的全合成及生物研究。
ChemMedChem. 2023 Sep 15;18(18):e202300235. doi: 10.1002/cmdc.202300235. Epub 2023 Jul 20.
8
Evaluation of synthesized biosurfactants as promising corrosion inhibitors and alternative antibacterial and antidermatophytes agents.评价合成生物表面活性剂作为有前途的腐蚀抑制剂以及替代抗菌和抗真菌剂。
Sci Rep. 2023 Feb 14;13(1):2585. doi: 10.1038/s41598-023-29715-5.
9
Effects of antibiotics on bacterial cell morphology and their physiological origins.抗生素对细菌细胞形态的影响及其生理起源。
Biochem Soc Trans. 2022 Oct 31;50(5):1269-1279. doi: 10.1042/BST20210894.
10
Antibiotic treatments to mothers during the perinatal period leaving hidden trouble on infants.围生期母亲使用抗生素治疗给婴儿留下隐患。
Eur J Pediatr. 2022 Sep;181(9):3459-3471. doi: 10.1007/s00431-022-04516-6. Epub 2022 Jun 10.
本文引用的文献
1
Serious infection in an adult due to penicillin-tolerant group B streptococcus.成人因耐青霉素B族链球菌引起的严重感染。
Arch Intern Med. 1981 Nov;141(12):1714-5.
2
Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.新型碳青霉烯类抗生素卡培霉素A和B的抗菌及β-内酰胺酶抑制活性
Antimicrob Agents Chemother. 1982 Apr;21(4):536-44. doi: 10.1128/AAC.21.4.536.
3
Nucleotide sequence of dihydrofolate reductase genes from trimethoprim-resistant mutants of Escherichia coli. Evidence that dihydrofolate reductase interacts with another essential gene product.来自大肠杆菌甲氧苄啶抗性突变体的二氢叶酸还原酶基因的核苷酸序列。二氢叶酸还原酶与另一种必需基因产物相互作用的证据。
Mol Gen Genet. 1982;187(1):72-8. doi: 10.1007/BF00384386.
4
Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.在敏感和耐药的大肠杆菌菌株中，亲脂性类似物米诺环素的转运与四环素不同。
Antimicrob Agents Chemother. 1982 Nov;22(5):791-9. doi: 10.1128/AAC.22.5.791.
5
In vitro activity of fludalanine combined with pentizidone compared with those of other agents.氟达拉宁与喷替齐酮联合使用的体外活性与其他药物的比较。
Antimicrob Agents Chemother. 1984 May;25(5):612-7. doi: 10.1128/AAC.25.5.612.
6
Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III.6-苯胺基尿嘧啶作为枯草芽孢杆菌DNA聚合酶III抑制剂的定量构效关系
J Med Chem. 1984 Feb;27(2):181-5. doi: 10.1021/jm00368a013.
7
[Prevalence and dispersion of plasmids conferring fosfomycin resistance in enterobacteria].[肠杆菌科细菌中携带磷霉素耐药质粒的流行情况及分布]
Pathol Biol (Paris). 1984 Sep;32(7):755-8.
8
Isolation and characterization of a phosphonomycin-resistant mutant of Escherichia coli K-12.大肠杆菌K-12磷霉素抗性突变体的分离与鉴定
J Bacteriol. 1972 Jun;110(3):935-44. doi: 10.1128/jb.110.3.935-944.1972.
9
Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review.对大环内酯类、林可酰胺类和B型链阳菌素类抗生素的诱导性耐药：耐药表型、其生物学多样性以及调控表达的结构元件——综述
J Antimicrob Chemother. 1985 Jul;16 Suppl A:63-90. doi: 10.1093/jac/16.suppl_a.63.
10
Contribution of two different mechanisms to erythromycin resistance in Escherichia coli.两种不同机制对大肠杆菌中红霉素耐药性的作用。
Antimicrob Agents Chemother. 1986 Nov;30(5):694-700. doi: 10.1128/AAC.30.5.694.
Zotero 插件